At-home spit tests are better than the standard blood test for identifying men who have a high genetic risk of developing aggressive prostate cancer, early research suggests.
The preliminary findings, presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, raise hopes of a potentially more accurate screening tool for a disease that claims around 12,000 lives a year in the UK.
